Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

June 12, 2025

Study Completion Date

July 12, 2025

Conditions
Ischemic Stroke
Interventions
DRUG

Ticagrelor 90 MG

Efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever ischemic stroke followed by 90 mg bid for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

DRUG

Cilostazol 100 MG

Efficacy and safety of 200 mg clopidogrel followed by 100 mg twice daily for 3 months will be assessed through NIHSS, mRS, duration of hospital stay, new ischemic stroke, and possible adverse effects.

Trial Locations (1)

33511

RECRUITING

Kafr Elsheikh University Hospital, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER